Reproduction is one of the most important factors affecting the success of cattle operations. Failure to conceive and early pregnancy failure are significant causes of calf loss and herd culling. Increased exposure to infectious agents can reduce reproductive performance.1

Vaccination against bovine viral diarrhea virus and bovine rhinotracheitis virus has been shown to protect against abortion and fetal infection1.

The Merck Animal Health BOVILIS® line of reproductive vaccines can be used prior to breeding as an aid in reduction of abortion and in prevention of fetal infection. It is the only vaccine line that offers protection against fetal and congenital infection beyond the first trimester of pregnancy.*

*Always read and follow label instructions to ensure the selected product is suitable for the animal to be vaccinated. Vaccination may not protect every animal that gets vaccinated.

BOVILIS® Vista® 5 CFP

Single-dose, 5-way modified-live vaccine for lasting protection against respiratory pathogens and reproductive diseases.

  • Minimum age: 3 months
  • Dosage: 2 mL
  • Administration: Subcutaneous

BOVILIS® Vista Once CFP

The only avirulent-live culture of Mannheimia haemolytica and Pasteurella multocida combined with a 5-way modified-live vaccine.

  • Minimum age: 3 months
  • Dosage: 2 mL
  • Administration: Subcutaneous

BOVILIS® Vista® BVD CFP

The only standalone subcutaneous BVD vaccine. Helps protect against respiratory disease and fetal infection, including persistently infected calves, due to bovine virus diarrhea (BVD) virus Types 1 & 2.

  • Minimum age: 3 months
  • Dosage: 2 mL
  • Administration: Subcutaneous

BOVILIS® Vista® 5 VL5 CFP

Single-dose, 5-way modified-live vaccine
combined with inactivated cultures
of Campylobacter and Leptospira

  • Minimum age: 6 months
  • Dosage: 2 mL
  • Administration: Subcutaneous

References

  1. Waldner CL, García Guerra A. Cow attributes, herd management, and reproductive history events associated with the risk of nonpregnancy in cow-calf herds in Western Canada. Theriogenology. 2013;79(7):1083-94.

BOVILIS® and VISTA® are registered trademarks of Intervet International B.V. Used under license.